FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be primary (originating in the brain) or secondary (metastatic, spreading to the ...

Like any specialized field, cancer biology has its fair share of technical vocabulary and jargon; two examples which you may be familiar with are the terms tumor suppressor (a gene whose loss or ...

A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered. The finding may ...

Imatinib (STI 571) is active in patients (PTS) with high-grade gliomas progressing on standard therapy No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the ...

A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered. The finding may ...

Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College ...

Although typically benign, about one-fifth of meningiomas, the most common primary brain tumors, recur despite complete surgical removal. The current meningioma classification does not consistently ...

PORTSMOUTH – Steve Talon, 36, of Barrington, is a groundskeeper for the Rochester School Department. He freely admits to being stubborn when it comes to paying attention to his medical needs. He said ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that abemaciclib, an oral cancer drug, may slow tumor growth in patients with aggressive meningiomas that have ...

A modified protein in benign-appearing meningiomas can reveal which are truly benign and which are more dangerous and require more aggressive treatment, researchers have discovered. The finding may ...